More tools:Markets·Screener·Research·Chat

GoodRx Holdings, Inc. Class A Common Stock (GDRX) Financial Statements

GoodRx Holdings, Inc. Class A Common Stock
SIC 7374 · SERVICES-COMPUTER PROCESSING & DATA PREPARATION
FIGI BBG00X0VP956
XNAS · usd
3.52▲ 0.04 (1.15%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close3.48
Day's Range3.43 – 3.55
52-Week Range1.77 – 5.81
Volume1.1M
Avg Volume1.7M
Share Statistics
Shares Outstanding
Employees697
ExchangeXNAS
Listed2020-09-23
Share count as of July 28, 2026
Loading Income Statement…
Key questions about GoodRx Holdings, Inc. Class A Common Stock (GDRX)
What is GoodRx Holdings, Inc. Class A Common Stock's Market Cap?
GoodRx Holdings, Inc. Class A Common Stock's Market Cap is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is GoodRx Holdings, Inc. Class A Common Stock's Enterprise Value?
GoodRx Holdings, Inc. Class A Common Stock's Enterprise Value is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is GoodRx Holdings, Inc. Class A Common Stock's Trailing P/E?
GoodRx Holdings, Inc. Class A Common Stock's Trailing P/E is 73.9×, based on as-reported figures from SEC (XBRL) filings.
What is GoodRx Holdings, Inc. Class A Common Stock's Price / Sales?
GoodRx Holdings, Inc. Class A Common Stock's Price / Sales is 1.5×, based on as-reported figures from SEC (XBRL) filings.
What is GoodRx Holdings, Inc. Class A Common Stock's EV / Revenue?
GoodRx Holdings, Inc. Class A Common Stock's EV / Revenue is 1.8×, based on as-reported figures from SEC (XBRL) filings.
What is GoodRx Holdings, Inc. Class A Common Stock's EV / EBITDA?
GoodRx Holdings, Inc. Class A Common Stock's EV / EBITDA is 8.4×, based on as-reported figures from SEC (XBRL) filings.
What is GoodRx Holdings, Inc. Class A Common Stock's Revenue (TTM)?
GoodRx Holdings, Inc. Class A Common Stock's Revenue (TTM) is $785.2M, based on as-reported figures from SEC (XBRL) filings.
What is GoodRx Holdings, Inc. Class A Common Stock's Net Income (TTM)?
GoodRx Holdings, Inc. Class A Common Stock's Net Income (TTM) is $16.2M, based on as-reported figures from SEC (XBRL) filings.
What is GoodRx Holdings, Inc. Class A Common Stock's EBITDA?
GoodRx Holdings, Inc. Class A Common Stock's EBITDA is $163.6M, based on as-reported figures from SEC (XBRL) filings.
What is GoodRx Holdings, Inc. Class A Common Stock's Diluted EPS (TTM)?
GoodRx Holdings, Inc. Class A Common Stock's Diluted EPS (TTM) is 0.05, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth-1.3%-4.4%-1.9%+0.4%
Costs and operating expenses:
Cost of revenue, exclusive of depreciation and amortization presented separately below
Product development and technology
Sales and marketing
General and administrative
Depreciation and amortization
Total costs and operating expenses
% of revenue88.2%92.8%88.4%92.5%
Operating income
% of revenue11.8%7.2%11.6%7.5%
Other expense, net:
Other income—
Interest income
Interest expense
Total other expense, net
Income before income taxes
Income tax expense
Net income
% of revenue4.3%0.6%2.8%0.6%
Basic (in usd per share)—
Diluted (in usd per share)—